Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.
Designing products that cater to the needs of those who use them seems logical for any competitive market. Yet tablets and capsules, which cause problems for large numbers of patients, remain the default approach for many pharmaceutical companies. Isn’t it time to take a more patient-centric approach? In this article, published in The Medicine Maker, HERMES PHARMA’s Dr. Thomas Hein (Director of Sales & Business Development) discusses:
- Why tablets and capsules present usability challenges for many patients
- The needs of specific patient groups such as the elderly
- Why ‘patient-centric’ design decisions are still an afterthought for many pharmaceutical companies
- Key considerations when developing user-friendly formulations